Yurdaydin C - Search Results

1

Non-invasive fibrosis score for hepatitis delta.

Lutterkort GL, Wranke A, Yurdaydin C, Budde E, Westphal M, Lichtinghagen R, Stift J, Bremer B, Hardtke S, Keskin O, Idilman R, Koch A, Manns MP, Dienes HP, Wedemeyer H, Heidrich B. Lutterkort GL, et al. Among authors: yurdaydin c. Liver Int. 2017 Feb;37(2):196-204. doi: 10.1111/liv.13205. Epub 2016 Aug 10. Liver Int. 2017. PMID: 27428078

2

Famciclovir treatment of chronic delta hepatitis.

Yurdaydin C, Bozkaya H, Gürel S, Tillmann HL, Aslan N, Okçu-Heper A, Erden E, Yalçin K, Iliman N, Uzunalimoglu O, Manns MP, Bozdayi AM. Yurdaydin C, et al. J Hepatol. 2002 Aug;37(2):266-71. doi: 10.1016/s0168-8278(02)00162-9. J Hepatol. 2002. PMID: 12127433 Clinical Trial.

3

Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia.

Bozkaya H, Yurdaydin C, Idilman R, Tüzün A, Cinar K, Erkan O, Bozdayi AM, Erden E, Uzun Y, Cetinkaya H, Uzunalimoglu O. Bozkaya H, et al. Among authors: yurdaydin c. Antivir Ther. 2005;10(2):319-25. Antivir Ther. 2005. PMID: 15865226 Clinical Trial.

4

Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.

Bozdayi G, Türkyilmaz AR, Idilman R, Karatayli E, Rota S, Yurdaydin C, Bozdayi AM. Bozdayi G, et al. Among authors: yurdaydin c. J Med Virol. 2005 Aug;76(4):476-81. doi: 10.1002/jmv.20386. J Med Virol. 2005. PMID: 15977237

5

P21 expression and its relation to disease activity and hepatocyte proliferation in chronic hepatitis B virus infection.

Varli M, Heper AO, Erden E, Uzunalimoğlu O, Yurdaydin C, Bozkaya H. Varli M, et al. Among authors: yurdaydin c. Turk J Gastroenterol. 2005 Mar;16(1):12-6. Turk J Gastroenterol. 2005. PMID: 16252182 Free article.

6

Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis.

Verdi H, Koytak ES, Onder O, Ergül AA, Cinar K, Idilman R, Erden E, Bozdayi AM, Yurdaydin C, Uzunalimoglu O, Bozkaya H. Verdi H, et al. Among authors: yurdaydin c. J Investig Med. 2005 Nov;53(7):353-9. doi: 10.2310/6650.2005.53706. J Investig Med. 2005. PMID: 16297361

7

Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment.

Uzun Y, Bozkaya H, Erden E, Cinar K, Idilman R, Yurdaydin C, Uzunalimoglu O. Uzun Y, et al. Among authors: yurdaydin c. J Gastroenterol Hepatol. 2006 Jun;21(6):977-81. doi: 10.1111/j.1440-1746.2006.04263.x. J Gastroenterol Hepatol. 2006. PMID: 16724981

8

Cytotoxic CD4 T cells in viral hepatitis.

Aslan N, Yurdaydin C, Wiegand J, Greten T, Ciner A, Meyer MF, Heiken H, Kuhlmann B, Kaiser T, Bozkaya H, Tillmann HL, Bozdayi AM, Manns MP, Wedemeyer H. Aslan N, et al. Among authors: yurdaydin c. J Viral Hepat. 2006 Aug;13(8):505-14. doi: 10.1111/j.1365-2893.2006.00723.x. J Viral Hepat. 2006. PMID: 16901280

9

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon.

Yurdaydin C, Bozkaya H, Onder FO, Sentürk H, Karaaslan H, Akdoğan M, Cetinkaya H, Erden E, Erkan-Esin O, Yalçin K, Bozdayi AM, Schinazi RF, Gerin JL, Uzunalimoğlu O, Ozden A. Yurdaydin C, et al. J Viral Hepat. 2008 Apr;15(4):314-21. doi: 10.1111/j.1365-2893.2007.00936.x. J Viral Hepat. 2008. PMID: 18307594 Clinical Trial.

10

Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis.

Değertekin H, Yalçin K, Yakut M, Yurdaydin C. Değertekin H, et al. Among authors: yurdaydin c. Liver Int. 2008 Apr;28(4):494-8. doi: 10.1111/j.1478-3231.2008.01673.x. Liver Int. 2008. PMID: 18339076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page